نتائج البحث - James Gajewski

تنقيح النتائج
  1. 1
    A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation

    A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation حسب James Gajewski, Viviana V. Johnson, S. Gerald Sandler, Antoine Sayegh, Thomas R. Klumpp

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia

    Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia حسب Gary J. Schiller, James Gajewski, Mary Territo, S D Nimer, Myung Lee, T Belin, R Champlin

    منشور في 1992
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

    Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program حسب P McGlave, Glenn E. Bartsch, Claudio Anasetti, R Ash, P Beatty, James Gajewski, NA Kernan

    منشور في 1993
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program

    Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program حسب P McGlave, Glenn E. Bartsch, Claudio Anasetti, R Ash, P Beatty, James Gajewski, NA Kernan

    منشور في 1993
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia

    Use of Leukemic Dendritic Cells for the Generation of Antileukemic Cellular Cytotoxicity Against Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia حسب Aniruddha Choudhury, James Gajewski, Jan C. Liang, Uday Popat, David F. Claxton, K. O. Kliche, Michael Andreeff, Richard E. Champlin

    منشور في 1997
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program

    Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program حسب Hugo Castro‐Malaspina, Richard E. Harris, James Gajewski, Norma K.C. Ramsay, Robert H. Collins, B. Dharan, Roberta King, H. Joachim Deeg

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Selective depletion of CD8+ T lymphocytes for prevention of graft- versus-host disease after allogeneic bone marrow transplantation

    Selective depletion of CD8+ T lymphocytes for prevention of graft- versus-host disease after allogeneic bone marrow transplantation حسب Richard E. Champlin, W. G. Ho, James Gajewski, Stephen A. Feig, M. Burnison, G Holley, PE Greenberg, K Lee, Irene Schmid, J. Giorgi

    منشور في 1990
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

    Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: Defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia حسب Börje S. Andersson, Peter F. Thall, Timothy Madden, Daniel R. Couriel, Xuemei Wang, Hai T. Tran, Paolo Anderlini, Marcos de Lima, James Gajewski, Richard E. Champlin

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation

    CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation حسب Sergio Giralt, J. P. Hester, Yang O. Huh, C Hirsch-Ginsberg, Gabriela Rondón, David Seong, M. Lee, James Gajewski, Koen van Besien, Issa F. Khouri

    منشور في 1995
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results

    Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplanta... حسب Narin Apisarnthanarax, Michèle L. Donato, M Körbling, Daniel R. Couriel, James Gajewski, Sergio Giralt, Issa F. Khouri, Chitra Hosing, Richard E. Champlin, Madeleine Duvic, Paolo Anderlini

    منشور في 2003
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce

    Impending Challenges in the Hematopoietic Stem Cell Transplantation Physician Workforce حسب James Gajewski, C. Frederick LeMaistre, Samuel Silver, Michael Lill, George B. Selby, Mary M. Horowitz, J. Douglas Rizzo, Helen E. Heslop, Claudio Anasetti, Richard T. Maziarz

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial

    Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transpl... حسب Richard T. Maziarz, Timothy Devos, Carlos Bachier, Steven C. Goldstein, José F. Leis, Steven M. Devine, Gabrielle Meyers, James Gajewski, Johan Maertens, Robert Deans, Wouter van’t Hof, Hillard M. Lazarus

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL

    SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIAL حسب Stephen D. Nimer, Janis V. Giorgi, James Gajewski, Nora Ku, Gary J. Schiller, K. Lee, M Territo, WINSTON HO, STEPHEN FEIO, Michael T. Selch, Valentin Isacescu, Thomas A. Reichert, Richard E. Champlin

    منشور في 1994
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Prevalence of Hematopoietic Cell Transplant Survivors in the United States

    Prevalence of Hematopoietic Cell Transplant Survivors in the United States حسب Navneet S. Majhail, Li Tao, Christopher Bredeson, Stella M. Davies, Jason Dehn, James Gajewski, Theresa Hahn, Ann A. Jakubowski, Steven Joffe, Hillard M. Lazarus, Susan K. Parsons, Kim Robien, Stephanie J. Lee, Karen M. Kuntz

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research

    HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for Internationa... حسب Michael R. Verneris, Stephanie J. Lee, Kwang Woo Ahn, Hai-Lin Wang, Minoo Battiwalla, Yoshihiro Inamoto, Marcelo Fernández-Viña, James Gajewski, Joseph Pidala, Reinhold Munker, Mahmoud Aljurf, Wael Saber, Stephen R. Spellman, John Koreth

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

    Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease... حسب Marcos de Lima, Αchilles Anagnostopoulos, Mark F. Munsell, Munir Shahjahan, Naoto T. Ueno, Cindy Ippoliti, Börje S. Andersson, James Gajewski, Daniel R. Couriel, Jorge E. Cortés, Michèle L. Donato, J. Neumann, Richard E. Champlin, Sergio Giralt

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy

    Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy حسب Issa F. Khouri, M.-S. Lee, Jorge Romaguera, Nadeem Q. Mirza, Hagop M. Kantarjian, M Körbling, Maher Albitar, Sergio Giralt, Brian L. Samuels, Paolo Anderlini, José Rodríguez, B von Wolff, James Gajewski, Fernando Cabanillas, R. Champlin

    منشور في 1999
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

    Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation حسب Daniel R. Couriel, Rima M. Saliba, Sergio Giralt, Issa F. Khouri, Börje S. Andersson, Marcos de Lima, Chitra Hosing, Paolo Anderlini, Michelle Donato, Karen R. Cleary, James Gajewski, J. Neumann, Cindy Ippoliti, Gabriela Rondón, Agueda Cohen, Richard Champlin

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years

    Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years حسب Raymond Wong, Sergio Giralt, Thomas G. Martin, Daniel R. Couriel, Αchilles Anagnostopoulos, Chitra Hosing, Börje S. Andersson, Pedro Cano, Munir Shahjahan, Cindy Ippoliti, Elihu H. Estey, John D. McMannis, James Gajewski, Richard E. Champlin, Marcos de Lima

    منشور في 2003
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report

    National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report حسب Shahrukh K. Hashmi, Christopher Bredeson, Rafael F. Duarte, Stephanie Farnia, Susan Ferrey, Courtney D. Fitzhugh, Mary E.D. Flowers, James Gajewski, Dennis A. Gastineau, Melissa A. Greenwald, Madan Jagasia, Patricia Martín, J. Douglas Rizzo, Kimberly Schmit-Pokorny, Navneet S. Majhail

    منشور في 2016
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: